Business Wire Feed
Viper Partners Announces Major National Initiative to Fuel Dental Sector Resurgence in 2026
MIAMI--(BUSINESS WIRE)--#2026Outlook--Viper Partners, the premier investment banking and M&A advisory firm specializing in dentistry since its founding in 2009, today announced a significant nationwide capital commitment aimed at accelerating mergers, acquisitions, and recapitalizations across the more...
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Presentation to take place at 7.30 am PT on Thursday, January 15, 2026BRISBANE, Calif.--(BUSINESS WIRE)--#CRISPR--Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation in vivo CRISPR gene editing platform to create potential one-time curative more...
Vivasure Medical Announces Acquisition by Haemonetics Corporation
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the company has been acquired by Haemonetics Corporation (NYSE: HAE) in a transaction valued up to €185M more...
Elucid Announces Broad Reimbursement for Quantitative Coronary Plaque Analysis
Widespread Reimbursement Advancements Recognize the Clinical Value of Plaque Analysis for Physicians and PatientsBOSTON--(BUSINESS WIRE)--#CoronaryArteryDisease--Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I Current Procedural more...
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed more...
Survey Finds Over 70% of Chinese Doctors Recommend “AI Doctor Services” Like Ant Group’s AQ for Everyday Health Needs
HANGZHOU, China--(BUSINESS WIRE)--A recent survey by Life Times, a well-known Chinese public health media outlet, shows that AI doctor services are broadly supported by doctors in China. Among 500 physicians from the country’s top-tier (tertiary) more...
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
Voluntary agreement will allow millions of Americans to purchase medicines at significantly discounted rates Agreement provides Johnson & Johnson pharmaceutical products an exemption from U.S. tariffs Company announces two new additional manufacturing facilities to be more...
Monnit Enters Japanese Market Through Partnership With Widetec
New Agreement Expands Wireless IoT MonitoringSALT LAKE CITY & TOKYO--(BUSINESS WIRE)--#IoT--Monnit, a global leader in Internet of Things (IoT) solutions, today announced a master partnership with Tokyo-based Widetec, a leading IT infrastructure company. Under the more...
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--$ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced more...
CONMED Corporation Announces Chief Financial Officer Transition
Todd Garner to step down as CONMED’s CFO, effective March 15, 2026, and remain In an Advisory Role Through November 2, 2026 Company Initiates Comprehensive Search for Next Chief Financial Officer CONMED Reaffirms Full-Year 2025 more...
GenNx360 Capital Partners Portfolio Company Nutra-Med Packaging Appoints Hany Salama as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--GenNx360 Capital Partners (“GenNx360”), a New York City-based private equity firm investing in middle-market industrial and business services companies, today announced the appointment of Hany Salama as Chief Executive Officer of its portfolio more...
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February more...
PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
--Savara Submitted the MOLBREEVI Biologics License Application (BLA) in December 2025 for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)--LANGHORNE, Pa.--(BUSINESS WIRE)--PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and more...
Reinsurance Group of America Announces Fourth Quarter Earnings Release Date, Webcast
ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA) plans to release fourth quarter earnings on Thursday, February 5, at approximately 4:15 p.m. Eastern Time. The release will be issued via newswire and will also more...
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal--(BUSINESS WIRE)--FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from more...
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
Not intended for UK Media Collaboration focuses on developing potential best in class siRNA-based treatment for a form of dilated cardiomyopathy Bayer to further strengthen cardiovascular portfolio and enter dynamic field of siRNA by partnering more...
Natus Sensory Appoints Arne Boye Nielsen to Board of Directors
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Natus Sensory, a global leader in sensory and diagnostic solutions, today announced the appointment of Arne Boye Nielsen to its Board of Directors, effective January 1, 2026. Arne brings more than 30 years more...
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON--(BUSINESS WIRE)--#eye--Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (IDE), authorizing the initiation of a more...
4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics
FDA IND clearance enabling the worldwide expansion of the INFLAM MOTION Phase 2a trial, involving major U.S. sites Advancing the first clinical proof of concept in OA with a first-in-class intra-articular GLP-1 agonist A holistic more...
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
The agreement builds on Organon’s cardiovascular disease portfolio, leveraging expertise to expand access to new treatments for patients with dyslipidemia, especially statin-intolerant patients. This collaboration addresses a critical gap in care that disproportionately affects women, more...
Pacific Prime Dubai Was Awarded AXA/Daman Market Excellence Award
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime Dubai, a global health insurance broker, risk specialist, and benefits specialist, concluded the year 2025 strongly with the AXA Global Healthcare/Daman Market Excellence Award. The award was presented by more...
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
LEIDEN, Netherlands--(BUSINESS WIRE)--#Adults--Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare more...
Novotech Appoints Anand Tharmaratnam as New CEO
SINGAPORE--(BUSINESS WIRE)--#ClinicalTrials--Novotech, a globally recognized full-service biotech clinical research organization (CRO), is pleased to announce the appointment of Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. Tharmaratnam brings nearly three decades of experience more...
Aptar Announces 2026 Quarterly Conference Call Dates
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any more...
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
BAAR, Switzerland--(BUSINESS WIRE)--Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, more...